Skip to main content
logo
Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
2.010
-0.080 (-3.83%)
At close: Jul 31, 2026, 4:00 PM EDT
1.950
-0.060 (-2.99%)
After-hours: Jul 31, 2026, 7:34 PM EDT

Cadrenal Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
2.314.0110.028.40.03
Cash & Short-Term Investments
2.314.0110.028.40.03
Cash Growth
-68.54%-59.99%19.23%25685.61%-
Other Receivables
0.010.010.040.04-
Total Trade Receivables
0.010.010.040.04-
Other Current Assets
0.540.310.060.050.7
Total Current Assets
2.864.3210.118.490.73
Net Property, Plant & Equipment
00.010.010.020.04
Other Long-Term Assets
00000.01
Total Assets
2.864.3310.128.520.78

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
0.820.651.50.170.4
Accrued Expenses
0.240.941.180.640.86
Short-Term Debt
----0.04
Current Portion of Leases
---0.020.02
Total Current Liabilities
1.061.592.680.831.33
Long-Term Debt
----0.55
Long-Term Leases
----0.02
Other Long-Term Liabilities
----4.42
Total Long-Term Liabilities
----4.99
Total Liabilities
1.061.592.680.836.33

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
00000.01
Additional Paid-in Capital
43.2541.733.1622.761.15
Retained Earnings
----15.07-6.71
Shareholders' Equity
1.82.747.447.69-5.55
Total Liabilities & Equity
2.864.3310.128.520.78

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
-000.020.64
Net Cash (Debt)
2.314.0110.028.38-0.61
Net Cash Growth
-68.54%-59.99%19.53%--
Net Cash Per Share
1.082.018.219.32-1.16
Book Value
1.82.747.447.69-5.55
Book Value Per Share
0.841.376.108.55-10.55
Tangible Book Value
1.82.747.447.69-5.55
Tangible Book Value Per Share
0.841.376.108.55-10.55
SEC Filings: 10-K · 10-Q